Verderame MF - Search Results

1

Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck.

Jaglowski JR, Zagon IS, Stack BC Jr, Verderame MF, Leure-duPree AE, Manning JD, McLaughlin PJ. Jaglowski JR, et al. Among authors: verderame mf. Cancer Chemother Pharmacol. 2005 Jul;56(1):97-104. doi: 10.1007/s00280-004-0929-4. Epub 2005 Mar 25. Cancer Chemother Pharmacol. 2005. PMID: 15791460

2

The effects of Tamoxifen and fish oil on mammary carcinogenesis in polyoma middle T transgenic mice.

Manni A, Xu H, Washington S, Aliaga C, Das A, Cooper T, Richie JP Jr, Prokopczyk B, Calcagnotto A, Trushin N, Van den Heuvel JP, Hamilton C, Demers LM, Liao J, Verderame MF, El-Bayoumy K. Manni A, et al. Among authors: verderame mf. Horm Cancer. 2011 Aug;2(4):249-59. doi: 10.1007/s12672-011-0078-2. Horm Cancer. 2011. PMID: 21769696

3

Functional significance of gastrin gene expression in human cancer cells.

Smith JP, Verderame MF, Ballard EN, Zagon IS. Smith JP, et al. Among authors: verderame mf. Regul Pept. 2004 Mar 15;117(3):167-73. doi: 10.1016/j.regpep.2003.10.013. Regul Pept. 2004. PMID: 14749036

4

Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.

Xu H, Washington S, Verderame MF, Manni A. Xu H, et al. Among authors: verderame mf. Breast Cancer Res Treat. 2008 Nov;112(2):255-61. doi: 10.1007/s10549-007-9866-3. Epub 2007 Dec 21. Breast Cancer Res Treat. 2008. PMID: 18097746

5

The opioid growth factor (OGF)-OGF receptor axis uses the p16 pathway to inhibit head and neck cancer.

Cheng F, Zagon IS, Verderame MF, McLaughlin PJ. Cheng F, et al. Among authors: verderame mf. Cancer Res. 2007 Nov 1;67(21):10511-8. doi: 10.1158/0008-5472.CAN-07-1922. Cancer Res. 2007. PMID: 17974995

6

Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells.

Jun JY, Griffith JW, Bruggeman R, Washington S, Demers LM, Verderame MF, Manni A. Jun JY, et al. Among authors: verderame mf. Breast Cancer Res Treat. 2008 Jan;107(1):33-40. doi: 10.1007/s10549-007-9533-8. Epub 2007 Feb 27. Breast Cancer Res Treat. 2008. PMID: 17333337

7

Activation of protein kinase A (PKA) signaling mitigates the antiproliferative and antiinvasive effects of alpha-difluoromethylornithine in breast cancer cells.

Xu H, Washington S, Verderame MF, Manni A. Xu H, et al. Among authors: verderame mf. Breast Cancer Res Treat. 2008 Jan;107(1):63-70. doi: 10.1007/s10549-007-9536-5. Epub 2007 Feb 27. Breast Cancer Res Treat. 2008. PMID: 17333334

8

Overexpression of the opioid growth factor receptor potentiates growth inhibition in human pancreatic cancer cells.

Zagon IS, Verderame MF, Hankins J, McLaughlin PJ. Zagon IS, et al. Among authors: verderame mf. Int J Oncol. 2007 Apr;30(4):775-83. Int J Oncol. 2007. PMID: 17332915

9

Overexpression of the opioid growth factor receptor downregulates cell proliferation of human squamous carcinoma cells of the head and neck.

McLaughlin PJ, Verderame MF, Hankins JL, Zagon IS. McLaughlin PJ, et al. Among authors: verderame mf. Int J Mol Med. 2007 Mar;19(3):421-8. Int J Mol Med. 2007. PMID: 17273790

10

Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells.

Jun JY, Griffith JW, Bruggeman R, Washington S, Demers LM, Verderame MF, Manni A. Jun JY, et al. Among authors: verderame mf. Breast Cancer Res Treat. 2007 Sep;105(1):29-36. doi: 10.1007/s10549-006-9432-4. Epub 2006 Dec 2. Breast Cancer Res Treat. 2007. PMID: 17143592

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results